Las Vegas, USA, March 03, 2022 (GLOBE NEWSWIRE) -- External Defibrillators Market Anticipated to Witness a Tremendous CAGR of 3.44% by 2026, Analyzes DelveInsight
The demand for External Defibrillators is primarily associated with the growing incidence of cardiac disorders such as arrhythmias, bradycardias, among others, rise in the geriatric population, integration of advanced technology, growing investments by government and private manufacturers, and rising awareness programs regarding cardiovascular disorders leading to more usage of External Defibrillators, leading to a direct rise in the External Defibrillators market.
DelveInsight's External Defibrillators Market Insights and Forecast report provides the current and forecast External Defibrillators, upcoming innovation in the devices, individual market shares of the devices, challenges, drivers and barriers, market trends, and key competitors in the External Defibrillators Market scenario.
Some of the essential takeaways from the External Defibrillators Market report:
- According to DelveInsight analysis, North America is expected to dominate the overall External Defibrillators Market during the forecasted period.
- Key External Defibrillators companies proactively working in the market include ZOLL Medical Corporation, Koninklijke Philips N.V., BPL Medical Technologies, Mediana Co., Ltd, CU Medical System Inc., Stryker, Shenzhen Mindray Bio-Medical Electronics Co. Ltd, SCHILLER, Bexen Cardio, Nihon Kohden Corporation, Shenzhen Comen Medical Instruments Co., Ltd., Progetti S.r.l., Starker Medical SL, HEARTHERO, Kestra Medical Technologies, Inc., Trivitron Healthcare, Amiitalia, Shanghai Huifeng Medical Instrument Co., Ltd, Metrax GmbH, Meditech Equipment Co., Ltd, among others.
- As per DelveInsight estimates, the Global External Defibrillators market is expected to surge at a substantial CAGR of 3.44% during the forecast period from 2021 to 2026.
- In August 2021, Kestra™ Medical Technologies, Inc. received the premarket US FDA approval for the ASSURE® Wearable Cardioverter Defibrillator (WCD) system.
- In November 2020, HeartHero has been granted the CE mark for Elliot, a portable, lightweight automated external defibrillator.
- In July 2020, Phillips received 510(k) clearances from the FDA for its HeartStart FR3 Defibrillators.
To pick on the latest highlights related to External Defibrillators get the snapshot of the key highlights entailed in the External Defibrillators Market Report.
External Defibrillators Overview
Defibrillators are a type of medical device that restores a normal heartbeat by sending an electric pulse or shock to the heart. They are used to prevent or correct an arrhythmia, a heartbeat that is uneven or that is too fast or too slow. External Defibrillators constitute portable, life-saving devices designed to treat several heart diseases such as cardiac arrest, a medical condition in which the heart stops beating suddenly and unexpectedly. These are mainly of automated and semi-automated type. The demand for External Defibrillators is increasing due to the rising prevalence of heart-associated disorders such as arrhythmias, bradycardia, hypertension which could ultimately lead to a heart attack.
External Defibrillators Market Insight
Geographically, the Global External Defibrillators market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share, North America is expected to dominate the overall External Defibrillators market during the forecast period. This domination is due to the growing prevalence of cardiovascular diseases, access to better healthcare infrastructure coupled with the presence of major External Defibrillators market players in the region. Further, in the United States, the risk of being affected by cardiovascular disease is increasing dramatically. Also, the presence of key manufacturers in the region such as Stryker, ZOLL, Phillips, among others in the region will surge the external defibrillators market.
For instance, in 2019, Stryker launched LIFEPAK® CR2 External Defibrillators with LIFELINK central™ AED Program Manager in the United States.
Due to the rising burden of cardiovascular diseases in the European region countries and the Asian countries, Europe and Asia-Pacific region will have massive future growth potential for the Global External Defibrillators.
Learn more about the Several Uses of External Defibrillators @ External Defibrillators Usage Assessment
External Defibrillators Market Dynamics
The increasing burden of hypertension among the population across the globe, as well as increasing cardiovascular disorders such as arrhythmias, bradycardias serve as a potential factor for bolstering the External Defibrillators market. In addition rising old age population, those who are more prone to develop heart-associated problems are likely to augment the External Defibrillators market. Also, the rising healthcare costs, improving healthcare infrastructure, technological advancements, increase in disposable income in growing economies are other aspects in favor of boosting the External Defibrillators market.
In addition, various commercialization activities including collaborations, product launch, merger acquisition, and others in the field of External Defibrillators are also projected to fuel the market. Moreover, the rising initiative by the state for the installation of External Defibrillators at public places apart from hospitals aiming to prevent sudden cardiac arrest is also a prominent factor contributing to the External Defibrillators market growth. The rapid technological innovations, favorable government regulation are also some of the factors that are anticipated to push the External Defibrillators market in the coming years.
However, certain factors such as lack of awareness regarding early corrective measures about Sudden Cardiac Arrest (SAC) and strict regulatory approval process might impede the External Defibrillators market.
To gain a better understanding of the COVID-19 impact on External Defibrillators get a snapshot of the External Defibrillators Impact by COVID-19
Scope of the External Defibrillators Market Report
- Coverage: Global
- Study Period: 2021-2026
- Market Segmentation By Product Type: Non-Wearable [Semi-Automated, Automated] and Wearable
- Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis
- Product Profiles
- Case Studies
- KOL's Views
- Analyst's View
Delveinsight’s Analysis: The Global External Defibrillators Market was valued at USD 4.45 billion in 2020, growing at a CAGR of 3.44% during the forecast period from 2021 to 2026 to reach USD 5.43 billion by 2026.
Know more about which MedTech player is set to dominate the market @ Key External Defibrillators Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | External Defibrillators Key Factors Analysis |
| 5 | External Defibrillators Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on External Defibrillators Market |
| 7 | External Defibrillators Market Layout |
| 8 | External Defibrillators Market Global Company Share Analysis – Key 3-5 Companies |
| 9 | External Defibrillators Company and Product Profiles |
| 9.1 ZOLL Medical Corporation 9.2 Koninklijke Philips N.V. 9.3 BPL Medical Technologies 9.4 Stryker 9.5 Mediana Co., Ltd 9.6 CU Medical System Inc. 9.7 Shenzhen Mindray Bio-Medical Electronics Co. Ltd, 9.8 SCHILLER 9.9 Bexen Cardio 9.10 Nihon Kohden Corporation 9.11 Shenzhen Comen Medical Instruments Co., Ltd. 9.12 Progetti S.r.l. 9.13 Starker Medical SL 9.14 HEARTHERO 9.15 Kestra Medical Technologies, Inc. | |
| 10 | Project Approach |
| 11 | KOL Views |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
Gain rich insights about the latest External Defibrillators regulatory approvals @ External Defibrillators Regulatory Landscape And Patent Analysis
Related Reports
Defibrillators Market By Product Type, By Type, By End User, By Geography is expected to grow at a steady CAGR. The report delivers an in-depth understanding of Defibrillators and the historical and forecasted market trends, market drivers, market barriers, and key Defibrillators companies such as Medtronic, Abbott, Boston Scientific Corporation, Stryker, Koninklijke Philips N.V., Zoll Medical Corporation, Biotronik, Nihon Kohden Corporation, and others.
Congestive Heart Failure Market
DelveInsight's "Congestive Heart Failure (CHF) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the CHF, historical and forecasted epidemiology, market trends, market drivers, market barriers and key Congestive Heart Failure companies such as Novartis, Boehringer Ingelheim, and Eli Lilly, Bayer and Merck, AstraZeneca, Amgen, Otsuka Pharmaceutical, Cytokinetics, Mesoblast, and others.
Tissue Heart Valves Market By Product Type, By Type, By End User, By Geography is expected to grow at a steady CAGR. The report delivers an in-depth understanding of Tissue Heart Valves and the historical and forecasted Tissue Heart Valves market trends, market drivers, market barriers, and key Tissue Heart Valves companies involved such as Abbott, Boston Scientific Corporation, CryoLife, Edward Lifesciences Corporation, Medtronic, Sorin Group (LivaNova PLC), and others.
Heart Failure with Preserved Ejection Fraction (HFpEF) Pipeline
DelveInsight’s, “Heart Failure with Preserved Ejection Fraction (HFpEF) Pipeline Insight, 2022,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Heart Failure with Preserved Ejection Fraction (HFpEF) pipeline landscape. It covers the pipeline drug profiles, including clinical, non-clinical stage products, and key companies involved such as Eli Lilly and Company, Novo Nordisk, Actelion Pharmaceuticals, AstraZeneca, Palatin Technologies, MyoKardia, Stealth BioTherapeutics Inc, Pfizer, Asklepios Biopharmaceutical, Cardiol Therapeutics, Gilead Sciences, and others.
Transcatheter Heart Valve Replacement Devices Market
DelveInsight’s ‘Transcatheter Heart Valve Replacement Devices (THVR) Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of THVR and the historical and forecasted THVR market trends, market drivers, market barriers and key Transcatheter Heart Valve Replacement Devices companies involved such as Edwards Lifesciences, Medtronic, Livanova plc, Abbott, Boston Scientific Corporation, CryoLife Inc, and others.
Congestive Heart Failure Treatment Devices Market
DelveInsight’s ‘Congestive Heart Failure Treatment Devices -Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of congestive heart failure treatment devices and the historical and forecasted congestive heart failure treatment devices market trends, market drivers, market barriers and key Congestive Heart Failure Treatment Devices companies involved such as Abiomed, Medtronic, Abbott, Berlin Heart GmbH, Boston Scientific Corporation, HeartWare International, LivaNova PLC, and others.
Congenital Heart Defect Devices Market
DelveInsight’s ‘‘Congenital Heart Defect Devices-Market Insights, Competitive Landscape and Market Forecast-2026’' report delivers an in-depth understanding of ‘Congenital Heart Defect Devices and the historical and forecasted ‘Congenital Heart Defect Devices market trends, market drivers, market barriers, and unmet medical needs to curate best of the opportunities.
DelveInsight’s, “Heart Failure Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Heart Failure pipeline landscape. It covers the pipeline drug profiles, including clinical, non-clinical stage products, and key Heart Failure companies such as Bayer HealthCare Pharmaceuticals, Ionis Pharmaceuticals, Heartseed Inc, AstraZeneca, Amgen, Sardocor Corp., Intra-Cellular Therapies, Bristol Myers Squibb, Eli Lilly and Company, Palatin Technologies, Cardiora, and others.
Heart Pump Devices Market By Product, By Type, By Therapy, By End-User, and By Geography are expected to grow at a steady CAGR. The report delivers an in-depth understanding of Heart Pump Devices and the historical and forecasted Heart Pump Devices market trends, market drivers, market barriers, and key Heart Pump Devices companies involved such as Abbott Laboratories, Abiomed, Teleflex Incorporated, SynCardia Systems, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic Inc, Terumo Heart.
Interested to know more about the breakthrough happenings? Take a look at the posts below
- Cardiac Monitoring Devices Market is Booming
- What Factors are Shaping the Trends in the Implantable Cardiac Monitors Market?
- Boston Scientific starts recruitment for the EkoSonic™ Endovascular System
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
For more insights, visit Pharma, Healthcare, and Biotech News
